IBL Tool - Digital Library

Digital Library

Journal description

All volumes of the corresponding journal

All issues of the corresponding volume

All articles of the corresponding issues

163 results found

no	title	author	magazine	year	volume	issue	page(s)	type
1	Activation of mature dendritic cells via PKC agonist induces HIV-1 reactivation of latently infected cells	Benet, S.			3	S5	p. 10	article
2	Adoptive T cell as a strategy for targeted delivery of immune checkpoint therapy	Sung, J.			3	S5	p. 53	article
3	A modified viral outgrowth assay incorporating ultra-sensitive P24 measurements	Archin, N.			3	S5	p. 4	article
4	A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound	Lorenzi, J.			3	S5	p. 41	article
5	Assessing antiretroviral drug (ARV) bioavailability in HIV tissue reservoirs using in vitro and in vivo pharmacokinetic (PK) studies with human primary lymphoid endothelial cells and mice	Dyavar, S.			3	S5	p. 17	article
6	Association between time spent with residual viremia after achievement of virological suppression and type of first-line antiretroviral regimen	Lazzarin, A.			3	S5	p. 29	article
7	Balancing risk-benefit ratio in donors of gut biopsy samples for HIV persistence research	Routy, J.-P.			3	S5	p. 43	article
8	BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs	Huang, S.-H.			3	S5	p. 32	article
9	Blinded evaluation of ultrasensitive assays of HIV in plasma	Keating, S.M.			3	S5	p. 24-25	article
10	Brain macrophages in SIV-infected ART-suppressed macaques represent a functional latent reservoir	Clements, J.			3	S5	p. 8	article
11	Brief ATI does not alter the size or composition of the latent HIV-1 reservoir	Bar, K.J.			3	S5	p. 40-41	article
12	Broadly neutraliing antibody cocktail prevents the establishment of viral reservoir against a mixed SHIV challenge	Liu, P.-T.			3	S5	p. 17-18	article
13	CD32+ CD4+ T Cells are HIV transcriptionally active rather than a resting reservoir	Abdel-Mohsen, M.			3	S5	p. 9	article
14	CD32 does not mark the HIV-1/SIV latent reservoir	Osuna, C.E.			3	S5	p. 2	article
15	CD4+ T-cell activation does not lead to expression of latent infection	Kumar, N.A.			3	S5	p. 4	article
16	CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA	Spivak, A.M.			3	S5	p. 8-9	article
17	CD8 T cells from HIV positive individuals on ART have a skewed differentiation phenotype and impaired proliferative responses	Clutton, G.			3	S5	p. 35	article
18	Characterisation of immune exhaustion in natural killer cells and role in HIV infection	Garrido, C.			3	S5	p. 37	article
19	Characterizing HIV expression of proviruses during ART in tissues and blood	McManus, W.R.			3	S5	p. 20	article
20	Chronically treated HIV-positive subjects can naturally harbor extremely low viral reservoir	Gálvez, C.			3	S5	p. 56-57	article
21	Clonotypic differences in TCR reactivity to HIV-1 Gag TL9 in the context of HLA-B42 and HLA-B81	Anmole, G.			3	S5	p. 50-51	article
22	Comparative transcriptome profiles in HIV-infected persons according to their clinical phenotype	Psomas, C.K.			3	S5	p. 36-37	article
23	CXCR3/CCR6 double positive germinal center T follicular helper cells (GC TFH) harbor residual virus during cART initiated during hyperacute HIV infection	Ndhlovu, Z.			3	S5	p. 37	article
24	Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants	Warren, J.			3	S5	p. 39	article
25	Defining the nature of protective CD8+ T-cell response in lymph nodes of HIV elite controllers	Betts, M.			3	S5	p. 32	article
26	Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies	Allen, A.			3	S5	p. 50	article
27	Determinants of early ART initiation during primary HIV infection: implications for HIV cure research	Routy, J.-P.			3	S5	p. 43-44	article
28	Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue	Luttge, B.			3	S5	p. 4	article
29	Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals	Carrillo, M.S.			3	S5	p. 28	article
30	Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques	Hsu, D.C.			3	S5	p. 15-16	article
31	Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV	Macedo, A.B.			3	S5	p. 56	article
32	Disease-specific HIV Nef identified in multiple patients with neurological disorders and cancers	Lamers, S.			3	S5	p. 30	article
33	Diverse interferons restrict HIV-1 Infection in macrophages through activation of SAMHD1	Szaniawski, M.			3	S5	p. 33	article
34	DNA-PK regulates HIV transcription and latency by supporting the activity of RNA polymerase II and the recruitment of transcription machinery at HIV LTR	Tyagi, M.			3	S5	p. 12-13	article
35	Drug-induced modulation of cellular activation during latency reversal changes antigen processing and peptide presentation in primary CD4 T cells	Boucau, J.			3	S5	p. 37-38	article
36	Early lessons from shock and kill trials	Søgaard, O.S.			3	S5	p. 47	article
37	eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients	Davis-Gardner, M.E.			3	S5	p. 49	article
38	Effect of switching to integrase inhibitor on the HIV reservoir in ileum biopsies	Moron-Lopez, S.			3	S5	p. 44-45	article
39	Effect of tyrosine kinase inhibitors on the cytotoxic activity against HIV-1 infection	Rodríguez-Mora, S.			3	S5	p. 51-52	article
40	Effector memory T cells contribute to monotypic residual plasma virus production during long-term suppression	Aamer, H.			3	S5	p. 27-28	article
41	Enhancing infection-resistant cells for HIV cure in the non-human primate model	Peterson, C.W.			3	S5	p. 14-15	article
42	Enrichment of HIV proviral DNA from mononuclear leukocytes for next-generation sequencing of integration sites	Williams-Wietzikoski, C.			3	S5	p. 23	article
43	Evaluation of the in vivo capacity of broadly neutralising anti-HIV antibodies to eliminate latently infected cells from HIV-infected individuals using a novel humanised mouse model	Flerin, N.			3	S5	p. 16-17	article
44	Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort	Nonnemacher, M.R.			3	S5	p. 24	article
45	Follicular regulatory T cell dynamics in peripheral blood and lymphoid tissue during very early treatment initiation in HIV-1 clade C infection	Laher, F.			3	S5	p. 31	article
46	Fully MHC-matched allogeneic hematopoietic stem cell transplantation in SIV-infected, cART-suppressed Mauritian cynomolgus macaques indicates GVHD as a reservoir clearance mechanism	Wu, H.L.			3	S5	p. 19	article
47	Functional profiling of HIV-specific CTL clonotypes and their ability to reduce HIV reservoir	Lima, N.			3	S5	p. 35	article
48	Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir	Verneuil, A.			3	S5	p. 28-29	article
49	Genetic diversity and CTL escape burden in the replication-competent HIV reservoir in youth in a therapeutic HIV vaccine trial	Brumme, Z.L.			3	S5	p. 26-27	article
50	Genotypic and phenotypic characterization of replication-competent HIV clones from patients' reservoir	Mammano, F.			3	S5	p. 25-26	article
51	Gut and blood differ in mechanisms governing HIV transcription/latency	Telwatte, S.			3	S5	p. 22	article
52	Higher rectal p24 levels correlate with poor CD4 recovery in treated HIV infection	Howell, B.J.			3	S5	p. 42	article
53	High-throughput single-cell transcriptome analysis of immune cells from HIV-1 infected individuals before and after therapy	Bradley, T.			3	S5	p. 31	article
54	Histone lysine methyltransferases selectively restrict HIV in central memory T cells	Dobrowolski, C.			3	S5	p. 5-6	article
55	HIV antibody and T cell responses on ART are associated with HIV DNA but not RNA	Keating, S.M.			3	S5	p. 33	article
56	HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen	Gantner, P.			3	S5	p. 30	article
57	HIV integrates in genes regulating cell cycle, DNA damage, and viral transport	Lee, S.			3	S5	p. 26	article
58	HIV latency reversal using designed PKC modulators	Marsden, M.D.			3	S5	p. 18	article
59	HIV-1 mediated insertional activation of STAT5B and BACH2 promotes the formation of a viral reservoir in T regulatory cells	Cesana, D.			3	S5	p. 20	article
60	HIV-1 Nef dimeriation and AP-2 recruitment contribute to viral replication and T-cell loss in humanized mice	Shu, S.			3	S5	p. 52-53	article
61	HIV persistence in lymph nodes from virally suppressed individuals: residual production VS latency	Pardons, M.			3	S5	p. 25	article
62	HIV-1 populations can persist as active reservoirs in the CNS during ART treatment	Joseph, S.B.			3	S5	p. 25	article
63	HIV protease cleavage sites vaccine augments quality of T cell responses during ART	Omange, R.W.			3	S5	p. 53-54	article
64	HIV-1 proviruses which are integrated into cancer-related genes are inducible	Varabyou, A.			3	S5	p. 1	article
65	HIV-seroreversion dynamics after allogeneic stem cell transplantation	Salgado, M.			3	S5	p. 40	article
66	HIV-specific T cells expressing an X5-GPI artificial receptor can suppress hiv replication in vitro: implications for a cure strategy for HIV-positive individuals with hematologic malignancies	Patel, S.			3	S5	p. 53	article
67	HIV-specific T cells generated from HIV-naive adult and cord blood donors target a range of novel viral epitopes: implications for a cure strategy after allogeneic HSCT and CBT	Patel, S.			3	S5	p. 55	article
68	HIV viremia is the product of a small fraction of infected cells	Anderson, E.			3	S5	p. 26	article
69	Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1	Van Lint, C.			3	S5	p. 6	article
70	Identification of a promising new class of latency reversing agents	Gramatica, A.			3	S5	p. 1-2	article
71	Identification of macrophage reservoirs through tropism of HIV-1 envelope	Machado, V.			3	S5	p. 7	article
72	Immunocapture identification of myeloid cell-derived HIV in CSF that is evolutionarily divergent from plasma virus	Johnson, J.			3	S5	p. 42-43	article
73	Impact of time of ART initiation on HIV specific T cell functionality in perinatally infected children	Rinaldi, S.			3	S5	p. 38	article
74	Improved HIV-1 clearance with BIT225 in the HIV-1 infected humanised mouse model	Wilkinson, J.			3	S5	p. 47	article
75	Increased expression and phosphorylation of SAMHD1 in SIV and HIV encephalitis is associated with proliferation of brain macrophages	Lindgren, A.A.			3	S5	p. 13	article
76	Index				3	S5	p. 60-64	article
77	Infection of astrocytes by a virus isolated from CSF cells of an HIV-positive patient virologically suppressed with ART	Li, G.			3	S5	p. 23	article
78	Influence of sex as an intrinsic biological variable in a primary cell model of HIV latency	Macedo, A.B.			3	S5	p. 19	article
79	Insights into mechanisms of HIV reactivation from latency using RNA-Seq gene expression profiling in CD4+ T cells and their maturation subsets following treatment with latency reversing agents.	Beliakova-Bethell, N.			3	S5	p. 3	article
80	In situ multiplex RNA fluorescence imaging of SHIV1157ipd3N4 and anti-HIV CAR T cells to study CAR T cell trafficking to sites of viral reservoir in macaque lymphoid tissues	Eichholz, K.			3	S5	p. 50	article
81	Integration site-independent enhancement of latency reversal by HIV-1 Nef	Kuang, X.T.			3	S5	p. 4	article
82	Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer	Uldrick, T.S.			3	S5	p. 55-56	article
83	Intrinsic resistance of HIV-infected macrophages to CTL-mediated killing drives immune activation	Clayton, K.			3	S5	p. 36	article
84	Intrinsic resistance of HIV-1 to SAMHD1 restriction permits efficient macrophage infection	Plitnik, T.			3	S5	p. 22	article
85	In vitro and in vivo quantification of HIV-induced neuroinflammation and effect of antiviral agents in primary human microglia and a murine HAND model	Gavegnano, C.			3	S5	p. 18-19	article
86	In vivo massive expansion of a T-cell clone carrying a defective HIV genome: implication for the measurement of the HIV reservoir	Fromentin, R.			3	S5	p. 21-22	article
87	In vivo suppression of HIV rebound by didehydro-Cortistatin A, a ‘block-and-lock’ strategy for HIV-1 cure	Kessing, C.F.			3	S5	p. 47	article
88	Lack of transcriptional latency in infected primary cells in the presence of exosomes and cART	DeMarino, C.			3	S5	p. 11	article
89	Lymph node CA-DNA strongly correlates with CD4+Tc count, plasma viral load and CD4/CD8 ratio during chronic HIV infection	Salgado, G.			3	S5	p. 44	article
90	Majority of the latent reservoir resides in CD32a negative CD4+ T cells	Bertagnolli, L.N.			3	S5	p. 8	article
91	Measurement and characterization of the latent reservoir for HIV-1 in patients receiving solid organ transplant	Martin, A.			3	S5	p. 22-23	article
92	Mobilizing NK cells for an HIV Cure: NK cells can target and kill latently HIV-1-infected primary T cells following proviral reactivation	Checkley, M.			3	S5	p. 51	article
93	Modeling the graft-versus-viral-reservoir effect in a nonhuman primate model of HIV persistence	Peterson, C.W.			3	S5	p. 15	article
94	Molecular characterisation of the inhibitor didehydro-Cortistatin A with the HIV-1 Tat protein	Mediouni, S.			3	S5	p. 59	article
95	Multiple NF-κB elements in the LTR of HIV-1 subtype C coordinate with the auto-regulatory circuit of Tat to drive rapid establishment of latency	Chakraborty, S.			3	S5	p. 39	article
96	Myeloid-derived suppressor cells decrease T-cell responses to viral antigens and therapeutic conserved elements DNA vaccine and increase following analytic treatment interruption	Dross, S.			3	S5	p. 34	article
97	Next generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 reservoir size	Stone, M.			3	S5	p. 17	article
98	No evidence for ongoing HIV replication in lymph nodes during suppressive ART	McManus, W.R.			3	S5	p. 21	article
99	No residual virus replication in a randomised trial of dolutegravir intensification	Rasmussen, T.A.			3	S5	p. 41	article
100	Novel dual role of dendritic cells in priming de novo CTL responses while inhibiting memory CTL responses to HIV-1 through the PD-L1 pathway	Garcia-Bates, T.M.			3	S5	p. 36	article
101	Novel mechanisms of baricitinib to block reservoir seeding and HIV persistence	Kohler, J.			3	S5	p. 58	article
102	Novel SHIVs encoding transmitted/founder envs for latency and cure research	Bar, K.			3	S5	p. 18	article
103	Novel use of alprazolam as a potential HIV-1 latency reversing agent	Elbezanti, W.			3	S5	p. 52	article
104	Oral ABX464 reduces the HIV DNA reservoir IN CD4+ peripheral blood T cells	Steens, J.-M.			3	S5	p. 55	article
105	Pacific biosciences small molecule real-time (SMRT) deep sequencing detects significant viral population structure in brain vs non-brain autopsy tissues from combined antiretroviral therapy (cART)-positive subjects	Lamers, S.L.			3	S5	p. 29	article
106	Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques	Wu, Y.			3	S5	p. 56	article
107	Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo	Ward, A.			3	S5	p. 15	article
108	Persistence of antigen presenting cell-mediated HIV trans infection during cART	Rappocciolo, G.			3	S5	p. 38	article
109	Persistence of CD4+PD-1 high T cells despite long-term suppressive ART	Macatangay, B.			3	S5	p. 35-36	article
110	Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy	Ling, B.			3	S5	p. 15-16	article
111	Platelets from HIV-infected cART-treated patients carry infectious viruses and predict poor immunological recovery	Bomsel, M.			3	S5	p. 31	article
112	Preclinical development of a bispecific HIV x CD3 DART molecule that redirects T cells to kill HIV envelope (env)-expressing cells	Nordstrom, J.L.			3	S5	p. 48-49	article
113	Preservation of IL-17 producing γδ T cells and their role in the control of immune activation in HIV controllers: ANRS EP56 study	Weiss, L.			3	S5	p. 38	article
114	Productive HIV-1 infection upregulates CD32 in vitro and in vivo	Serra Peinado, C.			3	S5	p. 20-21	article
115	Properties of eCD4-Ig relevant to reducing the viral reservior	Farzan, M.			3	S5	p. 47-48	article
116	Quantification of undetectable plasma HIV RNA	Margot, N.			3	S5	p. 45	article
117	Quantitation of the CD4+ T cell and macrophage reservoirs in SIV-infected ART-suppressed macaques: two functional latent reservoirs	Clements, J.			3	S5	p. 11	article
118	QVOA coupled with digital p24 analysis enhances HIV reservoir quantification	Wonderlich, E.R.			3	S5	p. 10	article
119	Rapid antiretroviral therapy of blood donors with acute and recent HIV infection: a preliminary report from the Monitoring and Acute Treatment of HIV Study (MATHS)	van den Berg, K.			3	S5	p. 44	article
120	Re-evaluating the peptide repertoire of MHC-E	Brackenridge, S.			3	S5	p. 49-50	article
121	Regulation of HIV-1 provirus and CD4+ T cell biology by transcriptional coregulators	Nikolai, B.C.			3	S5	p. 4	article
122	Regulation of HIV-1 replication by Poly (ADP-ribose) polymerase-1 in CD4 T cells.	Llano, M.			3	S5	p. 4	article
123	Replicate Aptima VL testing detects residual viremia in most ART-treated adults	Bakkour, S.			3	S5	p. 23-24	article
124	Retinoic acid (RA) upregulates α4β7 on CD4+ T cells and activates latent reservoirs	Omalla, O.A.			3	S5	p. 33	article
125	Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells	Novis, C.L.			3	S5	p. 58	article
126	Safety and potential impact of auranofin on the viral reservoir in HIV positive individuals under mega-ART	Diaz, R.S.			3	S5	p. 43	article
127	Sequencing HIV proviruses over time provides new insights into reservoir decay	VanBelzen, D.J.			3	S5	p. 40	article
128	Single cell analysis of HIV latency reveals diverse proviral and host cell behaviour	Browne, E.P.			3	S5	p. 2	article
129	Single-cell RNA-Seq reveals transcriptional heterogeneity in latent and reactivated HIV-infected cells	Golumbeanu, M.			3	S5	p. 3	article
130	Single-cell transcriptomics to evaluate HIV latency establishment in primary CD4 T cells	De Armas, L.			3	S5	p. 11	article
131	Single romidepsin infusions do not increase HIV expression in persons on ART (A5315)	McMahon, D.			3	S5	p. 41-42	article
132	SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion	Okoye, A.A.			3	S5	p. 15-16	article
133	SIV proviral landscape differs from that of HIV-1 and shows gross hypermutation	Murray, A.J.			3	S5	p. 13	article
134	SIV-specific CD8 T cells are largely excluded from B cell follicles during early SIV infection	Li, S.			3	S5	p. 34	article
135	SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo	Dunham, R.M.			3	S5	p. 52	article
136	SMAC mimetics reverse HIV latency by selective activation of the non-canonical NF-κB pathway	Sampey, G.C.			3	S5	p. 51	article
137	Spread of HIV-DNA in CD4+ T-cells subsets depends on ART initiation timing	Gantner, P.			3	S5	p. 29-30	article
138	Stimulating cellular locomotion using α1PI therapy to eradicate reservoirs without adverse effects	Bristow, C.			3	S5	p. 45-46	article
139	Susceptibility to neutralization by bnAbs orrelates with infected cell binding for a panel of clade B HIV reactivated from latent reservoirs	Ren, Y.			3	S5	p. 32-33	article
140	Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors	Irlbeck, D.			3	S5	p. 58	article
141	Targeted screens identify new chromatin regulators of HIV latency	Turner, A.-M.			3	S5	p. 10	article
142	T-cell signaling pathways leading to reactivation of P-TEFb and HIV transcription elongation in resting memory T cells	Mbonye, U.			3	S5	p. 12-13	article
143	TCF-1 expression is associated with HIV-specific CD8+ T cell proliferative capacity	Rutishauser, R.			3	S5	p. 34	article
144	Temporary ART initiated during primary HIV-1 infection limits the viral reservoir but increases virus diversity upon therapy interruption	Verschoor, Y.L.			3	S5	p. 28	article
145	Testing cure approaches in NHPs: the Emory experience	Silvestri, G.			3	S5	p. 14	article
146	The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial	Symons, J.			3	S5	p. 42	article
147	The contribution of memory CD4+ T cell subset phenotype to latency reversal efficiency	Kulpa, D.A.			3	S5	p. 1	article
148	The critical importance of social sciences in early-phase HIV cure research: what's in it for biomedical HIV cure scientists?	Dube, K.			3	S5	p. 45	article
149	The genetic traits of full-length HIV sequenced from memory T cell subsets	Horsburgh, B.A.			3	S5	p. 13	article
150	The HIV-1 antisense transcript AST recruits the polycomb repressor complex 2 to the HIV-1 5’LTR and acts as a viral latency factor	Romerio, F.			3	S5	p. 8	article
151	The human IL-15 superagonist complex ALT-803 drives SIV-specific CD8+ T cells into B cell follicles	Webb, G.			3	S5	p. 48	article
152	The impact of ART duration on the infection of T cells within anatomic sites	Lee, E.			3	S5	p. 9	article
153	The latent reservoir as a genetically diverse archive recapitulating within-host HIV evolutionary history	Jones, B.			3	S5	p. 27	article
154	Therapeutic efficacy of optimized eCD4-Ig proteins in SHIV-infected rhesus macaques	Gardner, M.R.			3	S5	p. 49	article
155	The role of APOBEC 3G/3F in shaping early HIV-1 reservoir landscapes	Reddy, K.			3	S5	p. 27	article
156	Tissue macrophages are a major viral reservoir in male urethra of HIV-1-infected individuals under suppressive antiretroviral therapy	Bomsel, M.			3	S5	p. 21	article
157	Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes in lymph nodes and reduces SHIV RNA	Pavlakis, G.			3	S5	p. 48	article
158	Understanding persistence of the latent reservoir	Siliciano, R.F.			3	S5	p. 1	article
159	Upregulation of the Nrf2 antioxidant pathway characterizes the transition from productive to latent infection in CD4+ T cells	Shytaj, I.			3	S5	p. 6-7	article
160	Using barcoded HIV-1 to understand inducibility of the latent HIV-1 reservoir	Larragoite, E.			3	S5	p. 13	article
161	Validation of an unbiased screen method for the identification of secondary fungal metabolites reversing HIV-1 latency	Stoszko, M.			3	S5	p. 59	article
162	Visualization and quantification of HIV dissemination and reservoirs using in vivo imaging	Young, W.-B.			3	S5	p. 14	article
163	Whole genome sequencing of single HIV provirus and its proviral integration site for the study of HIV latency	Sun, C.			3	S5	p. 3-4	article

163 results found

Koninklijke Bibliotheek - National Library of the Netherlands